PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of annrheumdAnnals of the Rheumatic DiseasesCurrent TOCInstructions for authors
 
Ann Rheum Dis. Mar 2005; 64(Suppl 2): ii30–ii36.
PMCID: PMC1766865
Psoriasis pathophysiology: current concepts of pathogenesis
J Krueger and A Bowcock
Psoriasis vulgaris is a common skin disorder characterised by focal formation of inflamed, raised plaques that constantly shed scales derived from excessive growth of skin epithelial cells. The disease is defined by a series of linked cellular changes in the skin: hyperplasia of epidermal keratinocytes, vascular hyperplasia and ectasia, and infiltration of T lymphocytes, neutrophils, and other types of leucocyte in affected skin. In a relatively short period, psoriasis vulgaris has been conceptualised as a T lymphocyte mediated autoimmune disease and new biological therapies that target T cells have just entered routine clinical practice. Similarly, rapid progress has been made towards dissecting cellular and molecular pathways of inflammation that contribute to disease pathogenesis. This short review presents current pathogenic concepts that have emerged from genetic, genomic, and cellular information obtained in basic studies and from clinical studies of selective immune targeting drugs.
Figure 1
Figure 1
 The array of leucocyte subsets that appear in psoriasis vulgaris lesions. iDC, immature dendritic cell; NK-T, natural killer T (cells).
Figure 2
Figure 2
 Alternative pathways of leucocyte activation that converge to activate type 1 inflammatory genes which, in turn, regulate end stage inflammation in skin and the appearance of the psoriasis phenotype. BRL, Bonzo receptor ligand; DC, dendritic (more ...)
Articles from Annals of the Rheumatic Diseases are provided here courtesy of
BMJ Group